David B. Berger - Nov 1, 2021 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
EVP, Bus Ops & Compliance
Signature
David B. Berger
Stock symbol
TNDM
Transactions as of
Nov 1, 2021
Transactions value $
-$135,696
Form type
4
Date filed
11/3/2021, 04:45 PM
Previous filing
Oct 14, 2021
Next filing
Dec 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $18.9K +1K +23.55% $18.86 5.25K Nov 1, 2021 Direct F1
transaction TNDM Common Stock Sale -$121K -890 -16.96% $135.61 4.36K Nov 1, 2021 Direct F2, F3
transaction TNDM Common Stock Sale -$15K -110 -2.52% $136.39 4.25K Nov 1, 2021 Direct F2, F4
holding TNDM Common Stock 242 Nov 1, 2021 Berger Family Trust F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Stock Option Options Exercise -$18.9K -1K -1.54% $18.86 64K Nov 1, 2021 Common Stock 1K $18.86 Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon exercise of a stock option award.
F2 The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021.
F3 The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $135.05 to $136.00. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
F4 The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $136.32 to $136.53. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
F5 The securities are held by the Berger Family Trust dated April 16, 2008.
F6 The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
F7 The expiration date for these options is 10 years from the date of grant.